
0:00
18:56
Three fresh stories, one question: what happens when AI stops being a chatbot and starts doing the work of a lab? A swarm of AI agents reads millions of brain cells in minutes and surfaces a new hypothesis for neurodegeneration. A robotics startup bets that machines can learn a chemist's hands. And a pharma giant gives its scientists an AI research partner. We walk through what each story actually shows — and the long road from a half-hour hypothesis to a drug. Produced by Dr. Jake Chen.
D'autres épisodes de "Drug Discovery AI Talk"



Ne ratez aucun épisode de “Drug Discovery AI Talk” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








